Pharvaris
PHVS
83 hedge funds and large institutions have $1.44B invested in Pharvaris in 2025 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 39 increasing their positions, 8 reducing their positions, and 6 closing their positions.
388% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 8
383% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 6
82% more capital invested
Capital invested by funds: $793M → $1.44B (+$650M)
38% more funds holding
Funds holding: 60 → 83 (+23)
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
7.31% more ownership
Funds ownership: 82.65% → 89.96% (+7.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$38.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.7M |
| 3 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$19.7M |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$17.1M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$30.5M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.23M |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$3.94M |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$2.71M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.03M |
PHVS Hedge Fund Activity: Q3 2025 in Review
83 of the 7,644 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q3 2025, worth a combined $1.44B — up 82% from $793M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new PHVS positions and 6 closed out — a net gain of 23 holders — while 39 added to existing stakes and 8 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $38.5M. The largest seller was VR Adviser, cutting an estimated $30.5M.
- 83 institutional investors held Pharvaris (PHVS) as of Q3 2025, up from 60 in Q2 2025.
- Funds reported $1.44B of Pharvaris stock for Q3 2025, up 82% quarter-over-quarter.
- 29 funds opened new Pharvaris positions in Q3 2025 and 6 closed out, a net change of +23 holders.
- The largest Pharvaris buyer in Q3 2025 was Wellington Management Group, an estimated $38.5M added.
- The largest Pharvaris seller in Q3 2025 was VR Adviser, an estimated $30.5M sold.
Based on aggregated 13F filings for Q3 2025.